Fortem Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-9,608
Closed -$245K 145
2019
Q2
$245K Sell
9,608
-744
-7% -$18.4K 0.25% 91
2019
Q1
$271K Sell
10,352
-78
-0.7% -$1.92K 0.28% 78
2018
Q4
$240K Buy
+10,430
New +$232K 0.29% 78

Other funds holding NVO

Fortem Financial Group's NVO Position: Q3 2019 in Review

Fortem Financial Group sold out of Novo Nordisk (NVO) in Q3 2019, closing a stake of 9,608 shares — an estimated $245K sold.

Fortem Financial Group first reported a position in NVO in Q4 2018 and held it in 3 quarters. The position peaked at $271K in Q1 2019. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

  • Fortem Financial Group reported no remaining Novo Nordisk position as of Q3 2019 after selling out during the quarter.
  • Fortem Financial Group sold 9,608 Novo Nordisk shares in Q3 2019, an estimated $245K.
  • Fortem Financial Group first reported a position in Novo Nordisk in Q4 2018 and held it in 3 quarters.
  • Fortem Financial Group's Novo Nordisk position peaked at $271K in Q1 2019.
  • 564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on Fortem Financial Group's 13F filing for Q3 2019, filed 12 Nov 2019.